Healthcare provider profile · identity verified

William Konitsky

Internal Medicine · BETHEL PARK, PA · NPI 1215111844

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	723	211
Levothyroxine Sodium	Levothyroxine Sodium	511	133
Amlodipine Besylate	Amlodipine Besylate	446	113
Losartan Potassium	Losartan Potassium	352	97
Lisinopril	Lisinopril	332	91
Pantoprazole Sodium	Pantoprazole Sodium	269	82
Omeprazole	Omeprazole	254	69
Metformin Hcl	Metformin Hcl	249	65
Gabapentin	Gabapentin	233	47
Rosuvastatin Calcium	Rosuvastatin Calcium	231	69
Citalopram Hbr	Citalopram Hydrobromide	184	48
Metformin Hcl Er	Metformin Hcl	171	64
Hydrochlorothiazide	Hydrochlorothiazide	156	54
Alprazolam	Alprazolam	137	43
Trazodone Hcl	Trazodone Hcl	137	38
Albuterol Sulfate Hfa	Albuterol Sulfate	131	43
Atenolol	Atenolol	131	38
Simvastatin	Simvastatin	118	35
Eliquis	Apixaban	117	29
Metoprolol Succinate	Metoprolol Succinate	115	32
Glipizide Er	Glipizide	107	29
Jardiance	Empagliflozin	100	18
Metoprolol Tartrate	Metoprolol Tartrate	93	26
Lorazepam	Lorazepam	89	31
Tramadol Hcl	Tramadol Hcl	88	25
Escitalopram Oxalate	Escitalopram Oxalate	87	24
Fluticasone Propionate	Fluticasone Propionate	86	36
Sertraline Hcl	Sertraline Hcl	86	29
Tamsulosin Hcl	Tamsulosin Hcl	82	25
Clonazepam	Clonazepam	79	21
Zolpidem Tartrate	Zolpidem Tartrate	78	21
Synthroid	Levothyroxine Sodium	77	24
Pravastatin Sodium	Pravastatin Sodium	74	21
Carvedilol	Carvedilol	70	16
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	70	58
Methylprednisolone	Methylprednisolone	68	63
Famotidine	Famotidine	67	28
Allopurinol	Allopurinol	66	23
Duloxetine Hcl	Duloxetine Hcl	63	12
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	60	56
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	58	16
Meloxicam	Meloxicam	58	14
Furosemide	Furosemide	57	24
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	57	20
Venlafaxine Hcl Er	Venlafaxine Hcl	56	14
Potassium Chloride	Potassium Chloride	55	17
Valsartan	Valsartan	54	15
Alendronate Sodium	Alendronate Sodium	53	14
Clopidogrel	Clopidogrel Bisulfate	53	18
Montelukast Sodium	Montelukast Sodium	52	16
Ezetimibe	Ezetimibe	50	16
Mounjaro	Tirzepatide	46	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	41	12
Paroxetine Hcl	Paroxetine Hcl	39	13
Azithromycin	Azithromycin	38	37
Glipizide	Glipizide	37	suppressed
Irbesartan	Irbesartan	37	suppressed
Sucralfate	Sucralfate	37	suppressed
Januvia	Sitagliptin Phosphate	36	suppressed
Ondansetron Hcl	Ondansetron Hcl	36	12
Ibuprofen	Ibuprofen	33	suppressed
Nystatin	Nystatin	33	18
Spironolactone	Spironolactone	33	11
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	33	suppressed
Valacyclovir	Valacyclovir Hcl	33	14
Tizanidine Hcl	Tizanidine Hcl	32	suppressed
Tradjenta	Linagliptin	32	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	30	suppressed
Ozempic	Semaglutide	28	suppressed
Bupropion Xl	Bupropion Hcl	27	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	27	suppressed
Lovastatin	Lovastatin	27	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	26	suppressed
Warfarin Sodium	Warfarin Sodium	26	suppressed
Glimepiride	Glimepiride	24	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	24	suppressed
Topiramate	Topiramate	24	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	24	suppressed
Diclofenac Sodium	Diclofenac Sodium	23	suppressed
Donepezil Hcl	Donepezil Hcl	23	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	22	22
Ondansetron Odt	Ondansetron	22	14
Bumetanide	Bumetanide	21	suppressed
Celecoxib	Celecoxib	21	suppressed
Lansoprazole	Lansoprazole	21	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	21	suppressed
Amoxicillin	Amoxicillin	20	15
Diazepam	Diazepam	20	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	20	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	20	suppressed
Finasteride	Finasteride	20	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	20	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	19	suppressed
Mirtazapine	Mirtazapine	19	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	19	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	19	suppressed
Trulicity	Dulaglutide	19	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	17	11
Fluconazole	Fluconazole	17	suppressed
Humalog Kwikpen U-100	Insulin Lispro	17	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	17	17
Temazepam	Temazepam	17	suppressed
Azelastine Hcl	Azelastine Hcl	16	suppressed
Bupropion Hcl Sr	Bupropion Hcl	16	suppressed
Mirabegron Er	Mirabegron	16	suppressed
Nifedipine Er	Nifedipine	16	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	16	suppressed
Ventolin Hfa	Albuterol Sulfate	16	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	15	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	15	suppressed
Breo Ellipta	Fluticasone/Vilanterol	15	suppressed
Clobetasol Propionate	Clobetasol Propionate	15	12
Entresto	Sacubitril/Valsartan	15	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	15	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	15	suppressed
Meclizine Hcl	Meclizine Hcl	15	suppressed
Prednisone	Prednisone	15	suppressed
Propranolol Hcl	Propranolol Hcl	15	suppressed
Benazepril Hcl	Benazepril Hcl	14	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	14	suppressed
Oxycodone Hcl	Oxycodone Hcl	14	suppressed
Potassium Citrate Er	Potassium Citrate	14	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	13	12
Pregabalin	Pregabalin	13	suppressed
Betamethasone Diprop Augmented	Betamethasone/Propylene Glyc	12	suppressed
Buspirone Hcl	Buspirone Hcl	12	suppressed
Humulin R	Insulin Regular, Human	12	suppressed
Loperamide	Loperamide Hcl	12	suppressed
Acyclovir	Acyclovir	11	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	11	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	11	suppressed
Gemfibrozil	Gemfibrozil	11	suppressed
Incruse Ellipta	Umeclidinium Bromide	11	suppressed
Naproxen	Naproxen	11	suppressed
Ropinirole Hcl	Ropinirole Hcl	11	suppressed
Timolol Maleate	Timolol Maleate	11	suppressed
Xarelto	Rivaroxaban	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error